Study of IBI3016 in People With Mild or Moderate Hypertension Patients
Clinical trial NCT07556796 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07556796
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2027-10-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.